What bilirubin level in newborn jaundice requires a blood test?

Oct 08, 2022 Source: Cainiu Health

Dr. Zhou Xiaofeng

Introduction

For full-term infants, a bilirubin level exceeding 12.9 mg/dL, and for preterm infants exceeding 15 mg/dL, a blood test is required as a precaution to assess the severity of jaundice, determine whether treatment is necessary, rule out abnormal causes, and monitor treatment response. Physiological jaundice resolves spontaneously, while pathological jaundice is usually associated with conditions such as hemolytic disease or infection in newborns and requires prompt medical intervention.

Neonatal jaundice refers to a condition during the newborn period characterized by elevated bilirubin levels in the blood due to abnormal bilirubin metabolism, leading to yellow discoloration of the skin, mucous membranes, and sclera. If the jaundice level exceeds 12.9 mg/dL in full-term infants or 15 mg/dL in preterm infants, a blood test is recommended for safety reasons to rule out pathological causes.

If the jaundice level exceeds 12.9 mg/dL in full-term infants or 15 mg/dL in preterm infants, this indicates an abnormality. For safety, timely blood tests are necessary to assess the severity of jaundice, determine whether treatment is needed, and select appropriate interventions such as phototherapy, medication, or blood transfusion. Additionally, blood testing helps exclude other underlying conditions such as hemolytic diseases or liver disorders, enabling early detection, prompt management, reduced risk of potential complications, and monitoring of treatment effectiveness.

Jaundice is generally classified into physiological and pathological types. Physiological jaundice typically resolves spontaneously, whereas pathological jaundice is often associated with conditions such as hemolytic disease of the newborn, breastfeeding-related jaundice, or infections, and requires timely medical evaluation and treatment.

View All

What are the consequences of ABO hemolytic disease?

The main consequences of ABO hemolytic disease include neonatal jaundice, anemia, hepatosplenomegaly, bilirubin encephalopathy, and heart failure. This condition is primarily caused by ABO blood type incompatibility between mother and infant. If a newborn exhibits symptoms such as skin yellowing and lethargy, immediate medical attention is required. Neonatal jaundice: the infant develops yellowing of the skin and sclera shortly after birth.

View Full Answer

Why does neonatal jaundice occur when the mother has type O blood?

Under normal circumstances, neonatal jaundice in mothers with blood type O may be caused by factors such as the newborn's characteristics of bilirubin metabolism, improper breastfeeding, ABO hemolytic disease, glucose-6-phosphate dehydrogenase deficiency, or congenital biliary atresia. If related symptoms occur, it is recommended to seek timely medical evaluation and treatment at a reputable hospital. The specific analysis is as follows:

View Full Answer

How can infant jaundice be reduced quickly?

Infant jaundice may be caused by characteristics of neonatal bilirubin metabolism, insufficient feeding with reduced bowel movements, breast milk jaundice, neonatal hemolytic disease, neonatal infections, and other factors. It is recommended to seek timely medical attention, identify the underlying cause, and then improve the condition under a doctor's guidance through feeding adjustments, phototherapy, and other methods. With a doctor's approval, infants can also receive appropriate mild sun exposure by exposing their skin moderately in daily life.

View Full Answer

How can neonatal jaundice resolve quickly?

In general, neonatal jaundice may be caused by excessive bilirubin production, weak liver metabolism of bilirubin, breast milk jaundice, hemolytic jaundice, infectious jaundice, and other reasons. It is recommended to seek timely medical attention, identify the underlying cause, and then improve the condition under a doctor's guidance through general treatment, medication, phototherapy (blue light irradiation), and other methods.